A Phase II Trial of R115777 [tipifarnib] (NSC #702818) in Patients With Advanced Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Tipifarnib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 13 Jun 2012 Actual patient number is 62 according to ClinicalTrials.gov.
- 13 Jun 2012 Actual end date (Jul 2006) added as reported by ClinicalTrials.gov.
- 13 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.